$BACK
IMAC Holdings, Inc. Stock $back

$back Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223018358 Filed on May 19, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$1.344M	$2.093M	$3.895M
YoY Change	-73.3%	-46.26%	27.29%
Cost Of Revenue	$180.0K	$270.0K	$460.5K
YoY Change	-54.69%	-41.36%	35.43%
Gross Profit	$1.170M	$1.830M	$3.435M
YoY Change	-74.76%	-46.72%	26.27%
Gross Profit Margin	87.06%	87.42%	88.18%
Selling, General & Admin	$2.180M	$3.890M	$6.085M
YoY Change	-63.44%	-36.07%	39.89%
% of Gross Profit	186.32%	212.57%	177.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$87.00K	$189.8K	$446.8K
YoY Change	-63.45%	-57.51%	6.37%
% of Gross Profit	7.44%	10.37%	13.01%
Operating Expenses	$2.725M	$5.790M	$6.532M
YoY Change	-60.13%	-11.37%	36.65%
Operating Profit	-$1.381M	-$3.696M	-$3.097M
YoY Change	-23.33%	19.33%	50.36%
Interest Expense	$22.36K	$2.467K	-$4.130K
YoY Change	372.39%	-159.73%	-97.71%
% of Operating Profit
Other Income/Expense, Net	-$22.36K	-$2.467K	-$13.17K
YoY Change	-47.94%	-81.27%
Pretax Income	-$1.403M	-$3.699M	-$3.162M
YoY Change	-23.9%	16.97%	41.8%
Income Tax
% Of Pretax Income
Net Earnings	-$1.403M	-$3.700M	-$3.162M
YoY Change	-23.9%	17.01%	41.84%
Net Earnings / Revenue	-104.41%	-176.75%	-81.18%
Basic Earnings Per Share	-$0.04	-$0.11	-$0.12
Diluted Earnings Per Share	-$0.04	-$3.36	-$119.9K
COMMON SHARES
Basic Shares Outstanding	33.02M shares	33.02M shares	26.37M shares
Diluted Shares Outstanding	33.14M shares	1.100M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$250.0K	$390.0K	$4.275M
YoY Change	-84.51%	-90.88%	-72.61%
Cash & Equivalents	$247.0K	$390.1K	$4.275M
Short-Term Investments
Other Short-Term Assets	$248.6K	$197.0K	$677.2K
YoY Change	-52.99%	-70.91%	-20.33%
Inventory
Prepaid Expenses
Receivables	$678.6K	$1.077M	$1.725M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.276M	$1.802M	$6.678M
YoY Change	-76.24%	-73.01%	-63.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$565.8K	$683.5K	$6.930M
YoY Change	-72.4%	-90.14%	19.69%
Goodwill
YoY Change
Intangibles	$901.9K	$1.200M
YoY Change	-83.15%
Long-Term Investments
YoY Change
Other Assets	$2.803M	$250.0K	$378.3K
YoY Change	696.66%	-33.91%	-44.37%
Total Long-Term Assets	$3.369M	$4.040M	$17.52M
YoY Change	-79.82%	-76.94%	14.3%
TOTAL ASSETS
Total Short-Term Assets	$1.276M	$1.802M	$6.678M
Total Long-Term Assets	$3.369M	$4.040M	$17.52M
Total Assets	$4.645M	$5.843M	$24.20M
YoY Change	-78.95%	-75.86%	-28.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.440M	$1.940M	$3.020M
YoY Change	16.19%	-35.76%	49.5%
Accrued Expenses	$950.0K	$1.000M	$1.472M
YoY Change	-35.38%	-32.08%	24.77%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$60.00K	$60.00K	$112.1K
YoY Change	-38.83%	-46.46%	-95.72%
Total Short-Term Liabilities	$3.924M	$3.532M	$5.238M
YoY Change	-14.01%	-32.57%	-20.63%
LONG-TERM LIABILITIES
Long-Term Debt	$40.00K	$50.00K	$111.8K
YoY Change	-56.52%	-55.27%	-49.19%
Other Long-Term Liabilities	$1.040M	$1.270M	$3.878M
YoY Change	-68.66%	-67.25%	-2.33%
Total Long-Term Liabilities	$1.080M	$1.320M	$3.989M
YoY Change	-68.33%	-66.91%	-4.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.924M	$3.532M	$5.238M
Total Long-Term Liabilities	$1.080M	$1.320M	$3.989M
Total Liabilities	$5.004M	$4.846M	$9.228M
YoY Change	-37.24%	-47.49%	16.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$51.62M	-$50.22M
YoY Change	55.43%
Common Stock	$33.28K	$33.02K
YoY Change	21.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$359.0K	$997.0K	$14.97M
YoY Change
Total Liabilities & Shareholders Equity	$4.645M	$5.843M	$24.20M
YoY Change	-78.95%	-75.86%	-28.04%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.403M	-$3.700M	-$3.162M
YoY Change	-23.9%	17.01%	41.84%
Depreciation, Depletion And Amortization	$87.00K	$189.8K	$446.8K
YoY Change	-63.45%	-57.51%	6.37%
Cash From Operating Activities	-$250.0K	-$1.400M	-$2.444M
YoY Change	-92.69%	-42.72%	39.66%
INVESTING ACTIVITIES
Capital Expenditures			-$218.1K
YoY Change			-281.78%
Acquisitions
YoY Change
Other Investing Activities	$80.00K	$1.050M	$2.060K
YoY Change		50870.87%	-100.37%
Cash From Investing Activities	$80.00K	$1.050M	-$216.1K
YoY Change	-309.75%	-585.93%	-68.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	30.00K	-$5.529K	-183.7K
YoY Change	-96.23%	-96.99%	-101.19%
NET CHANGE
Cash From Operating Activities	-250.0K	-$1.400M	-2.444M
Cash From Investing Activities	80.00K	$1.050M	-216.1K
Cash From Financing Activities	30.00K	-$5.529K	-183.7K
Net Change In Cash	-140.0K	-$373.1K	-2.844M
YoY Change	-94.74%	-86.88%	-121.89%
FREE CASH FLOW
Cash From Operating Activities	-$250.0K	-$1.400M	-$2.444M
Capital Expenditures			-$218.1K
Free Cash Flow		-$1.400M	-$2.226M
YoY Change		-37.1%	19.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001729944
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022Q1	BACK	Proceeds From Sale Of Operations ProceedsFromSaleOfOperations		usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2023Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross		usd
CY2022Q4	us-gaap	Goodwill Goodwill		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-38797
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	IMAC Holdings, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-0784691
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	3401 Mallory Lane
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Franklin
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37067
CY2023Q1	dei	City Area Code CityAreaCode	(844)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	266-4622
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33017049	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	390104	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	763211	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1077291	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2881239	usd
CY2023Q1	BACK	Deferred Compensation Current Portion DeferredCompensationCurrentPortion	137930	usd
CY2022Q4	BACK	Deferred Compensation Current Portion DeferredCompensationCurrentPortion	196119	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	196987	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	367358	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1802312	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4207927	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	683452	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1584714	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1200263	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1365457	usd
CY2023Q1	us-gaap	Security Deposit SecurityDeposit	246709	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	300430	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1910064	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3623078	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	3357036	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	5288965	usd
CY2023Q1	us-gaap	Assets Assets	5842800	usd
CY2022Q4	us-gaap	Assets Assets	11081606	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1936842	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1702740	usd
CY2023Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	205359	usd
CY2022Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	241666	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	44318	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	51657	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	19249	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	19898	usd
CY2023Q1	BACK	Liability To Issue Common Stock Current LiabilityToIssueCommonStockCurrent	329855	usd
CY2022Q4	BACK	Liability To Issue Common Stock Current LiabilityToIssueCommonStockCurrent	329855	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	996787	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1368016	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3532410	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3713832	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	43094	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	53039	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	5130	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	9375	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1265211	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2654104	usd
CY2023Q1	us-gaap	Liabilities Liabilities	4845845	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6430350	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33017758	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33017758	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33017049	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32935294	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	33017	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	32935	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	51182331	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	51138061	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-50218393	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-46519740	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	996955	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4651256	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5842800	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11081606	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2093362	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3894987	usd
CY2023Q1	us-gaap	Revenues Revenues	2093362	usd
CY2022Q1	us-gaap	Revenues Revenues	3894987	usd
CY2023Q1	BACK	Patient Expenses PatientExpenses	266231	usd
CY2022Q1	BACK	Patient Expenses PatientExpenses	460473	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	2313061	usd
CY2022Q1	us-gaap	Salaries And Wages SalariesAndWages	3899398	usd
CY2023Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	74543	usd
CY2022Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	370488	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1504878	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1815247	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	189823	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	446772	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1441012	usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-47429	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	5789548	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	7039807	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3696186	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3144820	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-13174	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	2467	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	4131	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2467	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17305	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3698653	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3162125	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3698653	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3162125	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33013165	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26365734	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	17953061	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	148560	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	32587	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3162125	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	14972083	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4651256	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	16650	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	27702	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3698653	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	996955	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3698653	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3162125	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	189824	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	446772	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	85891	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	40560	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1441012	usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-47429	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-184568	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	515701	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-170371	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-67258	usd
CY2023Q1	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	53721	usd
CY2022Q1	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	5231	usd
CY2023Q1	BACK	Increase Decrease In Right Of Use Lease Liability IncreaseDecreaseInRightOfUseLeaseLiability	47108	usd
CY2022Q1	BACK	Increase Decrease In Right Of Use Lease Liability IncreaseDecreaseInRightOfUseLeaseLiability	33396	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	234103	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	499819	usd
CY2023Q1	BACK	Increase Decrease In Patient Deposits IncreaseDecreaseInPatientDeposits	-36307	usd
CY2022Q1	BACK	Increase Decrease In Patient Deposits IncreaseDecreaseInPatientDeposits	11602	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1417578	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2592551	usd
CY2023Q1	BACK	Proceeds From Sale Of Operations ProceedsFromSaleOfOperations	1050000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	218139	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2060	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1050000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-216079	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	16650	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	148560	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	17285	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	178973	usd
CY2023Q1	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	4894	usd
CY2022Q1	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	4686	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5529	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-35099	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-373107	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2843729	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	763211	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7118980	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	390104	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4275251	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	2470	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	4599	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	163479	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5000	usd
CY2023Q1	BACK	Writeoffs Writeoffs	-82500	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	85979	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1365457	usd
CY2022Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	34000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zIT1oVipcLqh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline"><span id="xdx_86C_zLVB53yDuxia">Use of Estimates</span></span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses at the date and for the periods that the condensed consolidated financial statements are prepared. On an ongoing basis, the Company evaluates its estimates, including those related to insurance adjustments and provisions for doubtful accounts. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could materially differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_843_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zdYWWHSk23A5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline"><span id="xdx_864_z9qlEku36IE5">Reclassifications</span></span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. Specifically, we reclassified share-based compensation to salaries and benefits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3246412	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3476977	usd
CY2023Q1	BACK	Property And Equipment Excluding Construction PropertyAndEquipmentExcludingConstruction	683452	usd
CY2022Q4	BACK	Property And Equipment Excluding Construction PropertyAndEquipmentExcludingConstruction	1576792	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	7922	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	30000	usd
CY2023Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	75000	usd
CY2022Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	370000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	683452	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1584714	usd
CY2023Q1	us-gaap	Depreciation Depreciation	145472	usd
CY2022Q1	us-gaap	Depreciation Depreciation	235089	usd
CY2023Q1	BACK	Intangible Assets Including Goodwill Gross IntangibleAssetsIncludingGoodwillGross	8184148	usd
CY2023Q1	BACK	Working Capital WorkingCapital	1730000	usd
CY2022Q4	BACK	Working Capital WorkingCapital	500000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3700000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1400000	usd
CY2023Q1	BACK	Intangible Assets Accumulated Amortization Including Goodwill IntangibleAssetsAccumulatedAmortizationIncludingGoodwill	6983885	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1200263	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	4499796	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4499796	usd
CY2022Q4	BACK	Intangible Assets Including Goodwill Gross IntangibleAssetsIncludingGoodwillGross	13221015	usd
CY2022Q4	BACK	Intangible Assets Accumulated Amortization Including Goodwill IntangibleAssetsAccumulatedAmortizationIncludingGoodwill	11855558	usd
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1163270	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3044718	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	85979	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	163479	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1077291	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2881239	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3929864	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5053769	usd
CY2022Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	4500000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	44352	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	211683	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	131904	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	175873	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	175873	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	175873	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	175873	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	121118	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	956514	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	464230	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	410066	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	832959	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	734612	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	468745	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	236609	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	73823	usd
CY2023Q1	BACK	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	81691	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2428439	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	166441	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2261998	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	996787	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1265211	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	87412	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	104696	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	44318	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	51657	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	43094	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	53039	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	34373	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	27631	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	15813	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	9595	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	87412	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd

Files In Submission

Name	View Source	Status
0001493152-23-018358-index-headers.html	Edgar Link	pending
0001493152-23-018358-index.html	Edgar Link	pending
0001493152-23-018358.txt	Edgar Link	pending
0001493152-23-018358-xbrl.zip	Edgar Link	pending
back-20230331.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
back-20230331_cal.xml	Edgar Link	unprocessable
back-20230331_def.xml	Edgar Link	unprocessable
back-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
back-20230331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BACK
IMAC Holdings, Inc. Stock $back

2023 Q2 Form 10-Q Financial Statement

#000149315223018358 Filed on May 19, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BACK IMAC Holdings, Inc. Stock $back

2023 Q2 Form 10-Q Financial Statement

#000149315223018358 Filed on May 19, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BACK
IMAC Holdings, Inc. Stock $back